Neuroimaging of stroke and ischemia in animal models.
Magnetic resonance imaging (MRI) has dramatically changed our ability to diagnose and treat stroke as well as follow its evolution and response to treatment. Early stroke and ischemia can be visualized using diffusion-weighted imaging that utilizes water diffusion within tissues as a reporter for evolving neuropathology that reflects cytotoxic edema, particularly during the first several days after injury. T2-weighted imaging is used for evaluation of vasogenic edema but also is a reliable indicator of the volume and regional distribution of injured tissues. Perfusion-weighted imaging can be used to assess vascular function and also to evaluate potential tissues that might be rescued using therapeutic interventions (core vs. penumbra). Other imaging modalities such as magnetic resonance spectroscopy, diffusion tensor imaging, and susceptibility-weighted imaging are also being used to assist in rapid diagnosis of injured tissues following stroke. While visual analysis of MR data can provide some information about the evolution of injury, quantitative analyses allow definitive and objective evaluations of the injury and could be used to assess novel therapeutic strategies. We review here the basic uses of neuroimaging, focusing on MR approaches to assess stroke and ischemic injury in animal models.